Amdinocillin pivoxil
Coactin, Pivya (amdinocillin pivoxil) is a small molecule pharmaceutical. Amdinocillin pivoxil was first approved as Coactin on 1984-12-21.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Pivya
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Pivmecillinam hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PIVYA | Alembic Pharmaceuticals | N-216483 RX | 2024-04-24 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| pivya | New Drug Application | 2025-10-10 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
11 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | 1 | 3 | 3 | — | 7 |
| Infections | D007239 | EFO_0000544 | — | — | — | 2 | 2 | — | 4 |
| Communicable diseases | D003141 | — | — | — | — | 1 | 1 | — | 2 |
| Antibiotic prophylaxis | D019072 | — | — | — | — | 1 | 1 | — | 2 |
| Prostatic neoplasms | D011471 | — | C61 | — | — | — | 1 | — | 1 |
| Pyelonephritis | D011704 | EFO_1001141 | N10-N16 | — | — | — | 1 | — | 1 |
| Postoperative complications | D011183 | — | — | — | — | — | 1 | — | 1 |
| Urinary bladder neoplasms | D001749 | — | C67 | — | — | — | 1 | — | 1 |
| Cystectomy | D015653 | — | — | — | — | — | 1 | — | 1 |
| Urinary diversion | D014547 | — | — | — | — | — | 1 | — | 1 |
Show 1 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Bacteremia | D016470 | EFO_0003033 | R78.81 | — | — | 1 | — | — | 1 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | — | — | 1 | — | — | 1 |
| Kidney transplantation | D016030 | — | — | — | — | 1 | — | — | 1 |
| Bacteriuria | D001437 | — | R82.71 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chlamydia infections | D002690 | EFO_0007205 | A74.9 | — | 1 | — | — | — | 1 |
| Urethritis | D014526 | EFO_0003878 | N34 | — | 1 | — | — | — | 1 |
| Male genital diseases | D005832 | EFO_0009555 | N50.9 | — | 1 | — | — | — | 1 |
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Amdinocillin pivoxil |
| INN | pivmecillinam |
| Description | Pivmecillinam (INN) or amdinocillin pivoxil (USAN, trade names Selexid, Penomax and Coactabs) is an orally active prodrug of mecillinam, an extended-spectrum penicillin antibiotic. Pivmecillinam is the pivaloyloxymethyl ester of mecillinam.
|
| Classification | Small molecule |
| Drug class | penicillins |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](/N=C/N3CCCCCC3)[C@H]2SC1(C)C |
Identifiers
| PDB | — |
| CAS-ID | 32886-97-8 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1650818 |
| ChEBI ID | — |
| PubChem CID | 36272 |
| DrugBank | DB01605 |
| UNII ID | 1WAM1OQ30B (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,160 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
224 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use